BiomX (PHGE) Deferred Taxes (2019)
BiomX (PHGE) posted Deferred Taxes of $1222.0 for Q3 2019, up 94.9% sequentially from $627.0 in Q1 2019.
BiomX (PHGE) Deferred Taxes (2019) Analysis & Trends
BiomX has reported Deferred Taxes for 1 years, with the latest figure at $1222.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | BiomX | 362,449.94 | -805,550.06 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 1,222.00 |
| Mar 31, 2019 | 627.00 |